Main menu


White House announces $4 billion in funding for Covax, the global vaccine effort that Trump spurned

White House coronavirus adviser says vaccine companies plan to update shots to address variants

White House coronavirus adviser official discusses plans by  vaccine companies cope with COVID-19 variants

Andy Slavitt, White House senior adviser on the coronavirus response, said vaccine-producing companies plan to update their shots to address variants of the virus.

During a Washington Post live interview Thursday, he said the Pfizer and Moderna vaccines “work well for” the most prominent variant spreading throughout the United States, which is the one first identified in Britain.

He said that while the vaccines appear less effective against the variants first identified in Brazil and South Africa, they do produce some antibodies.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Schools: Is it safe to open schools? Yes, but ...a look at the considerations

COVID "Long haulers" --more background on their problems

How many people get ‘long COVID’ – and who is most at risk?

A few months ago, a young athletic guy came into my clinic where I’m an infectious disease physician and COVID-19 immunology researcher. He felt tired all the time, and, importantly to him, was having difficulty mountain biking. Three months earlier, he had tested positive for COVID-19. He is the kind of person you might expect to have a few days of mild symptoms before recovering fully. But when he walked into my clinic, he was still experiencing symptoms of COVID-19 and he could not mountain bike at the level he was able to before.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

The difficulties in enrolling teenagers for vaccine test trials.

 

 

Teenagers contract the novel coronavirus almost twice as often as younger children but vaccines authorized in the United States are mostly for adults — Moderna’s for 18 and older, Pfizer’s for 16 and up.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Oxford University begins major international trial of potential Covid-19 drug treatments

Most U.S. firms hit with COVID-19 safety fines aren't paying up--Reuters

(Reuters) - U.S. workplace safety regulators have announced more than $4 million in penalties on more than 300 employers they say put workers at risk during the COVID-19 pandemic.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Vaccine availability remains the big challenge before anticipated surge in cases, expert says

Studies: COVID-19 vaccines may stop spread of the virus as well as protecting recipient

Why one third of US Troops may be refusing the COVID vaccine

EU makes deals to get more vaccines, plans to tackle variants

BRUSSELS (AP) — Amid signs that more infectious coronavirus variants are spreading unchecked across Europe, governments and EU leaders scrambled Wednesday to speed up vaccine efforts that have been hampered by limited supplies and to fund ways to hunt down variants and counter them.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Trying to Vaccinate Homeless Patients Against COVID-19

... People experiencing homelessness are especially vulnerable to disease and often live in close quarters. Reaching them for COVID-19 vaccination is crucial, public health officials say, yet also presents some unique challenges. Addresses and phone numbers change constantly. Few of the people affected have reliable Internet access.

Also, the pandemic put a halt to many mobile clinics and other outreach efforts to homeless encampments; in the meantime, patients scattered or avoided the clinic for fear of infection.

"If they're experiencing homelessness, all bets are off," says Kevin Lindamood, CEO of Health Care for the Homeless in Baltimore, a community health clinic that treats 10,000 patients a year and recently started patient vaccinations. "It's incredibly hard to reach people even in non-COVID times."

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

UN says 130 countries have not received a single Covid vaccine dose

Administration announces $200 million to track virus variants

Lab studies suggest Pfizer and Moderna vaccines can protect against coronavirus variants

Pages

Subscribe to Philadelphia RSS
howdy folks
Page loaded in 1.099 seconds.